This radioimmunoassay for type I collagen mainly detects degradation products of the molecule in human serum samples. Type I collagen antigenicity in serum can be separated into two peaks by gel-filtration chromatography. The larger form represents collagen molecules (as shown by immunoblotting experiments), and (or) type I collagen with aminoterminal propeptide or intact procollagen molecules. The smaller form, the exact nature of which is not known, is quantitatively the principal antigenic form and is derived from degradation of type I collagen. The concentration of type I collagen in serum is increased mainly in cirrhotic patients, with or without active liver disease, but also somewhat in alcoholic patients without cirrhosis.
Fibrosis is characterized
by excessive deposition of collagen and other components of the extracellular matrix, which leads to a disturbed function of the organs involved. Normal liver contains approximately equal amounts of type I collagen, type ifi collagen, and basement-membrane collagen (1) (2) (3) . In fibrotic livers with cirrhosis, the total collagen content is increased by four-to sevenfold, all collagen types being increased by about the same extent (1, 3) . The most reliable method for assessing and measuring hepatic fibrosis is histological examination of a liver biopsy sample. However, this procedure is invasive (4). Furthermore, the quantification of liver fibrosis by use of hepatic biopsies is not entirely reliable, given the small size of the sample, the heterogeneous distribution of fibrosis (5, 6) , and the practical difficulties of using objective and quantitative methods such as colorimetry in these procedures (7) . Iterative biopsies are ethically questionable and only dubiously reliable for measuring the progression of liver fibrosis. Markers in serum would be very useful for assessing fibrosis or fibrogenesis in patients with liver diseases and for monitoring drug trials.
Since 1979, several attempts have been made to evaluate the metabolism of human connective tissue proteins by radioimmunoassay techniques (for reviews, see [8] [9] [10] [11] [12] . Much has been published on the N-terminal propeptide of type ifi procollagen (PIIINP) 3 (13-21) (34) . Preparation of antisera. Antibody to type I collagen was raised in rabbits as described previously (35). Antiserum to purified rabbit IgG was obtained from a goat by an established procedure.
Materials and Methods

Isolation
Radioiodination. We radiolabeled type I collagen with 125! using the Chloramine T method ( glycol solution in PBS. After 30-mm incubation at room temperature, the precipitate was collected by centrifugation at 5000 x g for 30 mm and the radioactivity measured. Nonspecific binding was measured by replacing specific antiserum with normal rabbit serum.
Radioimmunoassays.
In the standard inhibition assay (sequential saturation type), 0.1 mL of a 400-fold dilution of antiserum capable of binding 50% of the 1251-labeled collagen was incubated with 0.1 mL of diluted unlabeled standard human type I collagen in PBS or with 0.1 mL of human serum. After incubation for 24 h at 4#{176}C, we added '25I-labeled collagen and continued the assay as above.
Gel-filtration chromatography. We chromatographed 2-mL serum samples on a 1.6 x 130 cm column of Sephacryl S500 (Pharmacia) equilibrated in PBS containing 0.4 mL of Tween 20 surfactant per liter, eluting at a flow rate of 20 mLIh. We collected and assayed 2-mL fractions. Some of the serum samples were exposed to bacterial collagenase from Clostridium histolyticum (Sigma Chemical Co., St. Louis, MO) [according to Savolainen et al. (37) ] added directly to serum for a 24-h incubation at room temperature, before gel-filtration chromatography. Collagenase activity was stopped by the addition of EDTA (0.5 mmol/L final concentration).
Immunoblotting. Statistical analysis. The differences between the groups were analyzed by one-way analysis of variance and, if a statistically significant level was reached, Student's unpaired t-test with pooled variance was used. Data were normalized by logarithmic transformation before analysis.
Results
Radioimmunoassay.
With rabbit antiserum against human type I collagen we obtained a typical binding profile with the '251-labeled antigen. More than 85% of the total radioactivity was precipitated in the antibody-excess zone, indicating intact immunoreactivity of the radioiodinated type I collagen. The antiserum showed a strong reaction with the immunizing antigen and a weak one, if any, with other human collagens, PIIINP, elastin, or fibronectin (Figure 1) .
We established the inhibition assay for type I collagen, using a 400-fold dilution of the hyperimmune serum and
mL of sample (Figure 2). No significant inhibition was observed with other collagenous or noncol!agenous connective tissue proteins (not shown).
The minimal detectable dose for the assay was estimated 
Fig. 2. Typical standard curve for the determination of human type I collagen
Inset: Dilution of sera from a healthy subject (A) and a patient with alcoholic
cirrhosis (D)
at 600 pg by extrapolating the imprecision proffle ( Figure   3 ).
Type I collagen can be routinely detectable (coefficients of variation of replicates lower than 10%) in the concentration range between 30 and 1000 g/L (Figure 3) .
The precision was also estimated from the inter-assay coefficients of variation (Table 1) .
Analytical recovery of known amounts of type I collagen, 120-700 g/L, added to human serum was 102±7% (mean
± SD).
Dilution of normal or pathological sera showed a nonparallelism with the standard curve ( Figure 2 ). Detection of type I collagen-related antigens in sera of healthy subjects and patients with liver disease. healthy adult subjects. The upper limit of the reference interval (mean + 2 SD) was 197 g/L (Figure 4) . No sex-or age-related differences in type I collagen concentrations in serum were noted. Figure 4 depicts the results for patients with liver diseases. Type I collagen concentrations were significantly higher than in normal subjects in the following groups: AC (P <10-i), C + A1dH (P <10-a), IC (P <10-a), All (P <10_2), Aid (P <10), and A1cML (P <10-i).
A significant difference between the eight groups of patients was noted for serum type I collagen (F = 13.1,P <
10).
The results of this statistical comparison between groups are reported in Figure 4 .
Molecular mass determination of immunoreactive components in serum. Gel-filtration chromatography of various normal or pathological serum samples showed two fractions reacting with anti-type I: a high-molecular mass fraction eluting in the position of standard type I collagen and a low-molecular-mass fraction, which quantitatively was the main antigen ( Figure 5 ). When the serum was incubated with collagenase before chromatography, the type I antigenicity was recovered only in a fraction with molecular mass <15 000 Da ( Figure 5 ). 
Discussion
This reliable, reproducible radioimmunoassay for human type I collagen was found to be sufficiently sensitive to allow quantitative determination of related antigens released into the circulation in normal or pathological conditions. The type I collagen antigenicity appeared to be heterogeneous: nonparallel inhibition curves were produced by the biological samples as in other connectivetissue assays (13,15,28,30) , because the different peptides have different affinities for the antibody. We performed gel-ifitration experiments to define the size of these antigens, the collagenous nature of which was demonstrated by susceptibility to collagenase. Type I antigenicity was found in two fractions ( Figure 5) .
The high-molecular-mass component was eluted by gelifitration in the same position as acid-soluble human type I collagen and migrated in sodium dodecyl sulfate/polyacrylamide gel as a1(I) and a2(I) chains. It probably is intact, fully processed type I collagen, pC-or pN-collagen, procollagen itself, or some mixture of them.
The presence of such circulating high-molecular-mass antigens is not surprising, because (a) they also appeared on the gel-filtration proffles of human and rat sera for PHINP (15,37,39,40) , (b) these kinds of compounds were , personal communication) . The origin of these two antigenic fractions remains to be established. Because PICP (and PINP) is cleaved off when the collagen molecules are to be associated into fibrils, its measure estimates the amount of collagen that is being synthesized (12) . Conversely, our assay probably will measure degradation products from the tissue form of type I collagen. At present, little is known about the excretion and elimination of extracellular matrix proteins from the serum. Some information has been published recently on the clearance of PIIINP. The liver seems to play a key role in its elimination from the blood via the hepatic endothelial cells (41, 42) , which would also be the case for the other connective-tissue molecules, although the mechanisms may be different depending on the size of the antigen (41) (42) (43) .
In fibrotic and cirrhotic hepatic tissue, the contents of all collagen types are increased. In cirrhotic livers with a low amount of fibrosis, the ratio of type I to type Ill remains similar to that found in normal liver, whereas in livers with a high amount of fibrosis, type I collagen is the prevailing type and the ratio is >1 (1). So, in tissues, type ifi collagen could be characteristic of "early" fibrosis, as in active diseases with inflammation and cell necrosis, whereas type I collagen could be a component encountered predominantly in "late" fibrosis (1). For serum, the PIIINP results have been interpreted in earlier studies (13-14) in terms of increased liver collagen synthesis and deposition. The relationship between PIIINP and aminotransferase concentrations in serum suggests in fact that the peptide may be released during the active inflammatory phase of the disease by cleavage of tissue type ifi procollagen and thus reflects inflammation and necrosis and not necessarily fibrosis (12, 44) . By contrast, in this study, we have shown that the concentration of type I collagen in serum is predominantly increased in cirrhotic patients with or without active liver disease and thus is less related to liver activity than is PIIINP (Trinchet et al., ms. submitted for publication). Moreover, type I collagen was more increased in serum of alcoholic patients without cirrhosis (alcoholic hepatitis or minimal lesions) than in that of nonalcoholic patients (CPH, CAll, or All) without cirrhosis; this fact may reflect the progressive weakly reversible fibrosis that characterizes alcoholic liver disease.
Owing to the heterogeneity of the liver diseases, further studies are needed to determine the significance of the respective different connective-tissue variables in serum.
